Immunochemical detection of glycated β- and γ-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat

Molecular Vision

Volumn 12, Issue , 2006, Pages 1077-1085

  Ranjan, Mala ^a   Najak, Sujatha ^a   Rao, Beedu Sashidhar ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AUTOANTIBODY; BETA CRYSTALLIN; GAMMA CRYSTALLIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN G; LENS PROTEIN; POLYCLONAL ANTIBODY; STREPTOZOCIN; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; BODY WEIGHT; CATARACT; CATARACTOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID INTAKE; FOOD INTAKE; GLYCATION; HYPERGLYCEMIA; IMAGE ANALYSIS; IMMUNOASSAY; IMMUNOCHEMISTRY; LENS; MALE; MEDICAL ASSESSMENT; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; RAT; SPECTROFLUOROMETRY; STREPTOZOCIN DIABETES; TISSUE HOMOGENATE; WESTERN BLOTTING;

ANIMALS; AUTOANTIBODIES; BETA-CRYSTALLINS; BLOTTING, WESTERN; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; GAMMA-CRYSTALLINS; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOGLOBULIN G; IMMUNOLOGIC TECHNIQUES; LENS, CRYSTALLINE; MALE; RATS; RATS, WISTAR;

EID: 33748754110     PISSN: 10900535     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Harding JJ, van Heyningen R. Epidemiology and risk factors for cataract. Eye 1987; 1:537-41.
2. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001; 85:746-53.
3. Hockwin O, Kojima M, Muller-Breitenkamp U, Wegener A. Lens and cataract research of the 20th century: a review of results, errors and misunderstandings. Dev Ophthalmol 2002; 35:1-11.
4. Bron AJ, Brown NA, Harding JJ, Ganea E. The lens and cataract in diabetes. Int Ophthalmol Clin 1998; 38:37-67.
5. Harding JJ, Crabbe MJ. The lens: development, proteins, metabolism and cataract. In: Davson H, editor. The Eye. 3rd ed. Vol. 1B. Orlando: Academic Press, 1984. p. 207-492.
6. Stevens VJ, Rouzer CA, Monnier VM, Cerami A. Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci U S A 1978; 75:2918-22.
7. Mohammad A, Fraenkel-Conrat H, Olcott HS. The browning reaction of proteins with glucose. Arch Biochem 1949; 24:157-78.
8. Matsumoto K, Ikeda K, Horiuchi S, Zhao H, Abraham EC. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses. Biochem Biophys Res Commun 1997; 241:352-4.
9. Monnier VM, Stevens VJ, Cerami A. Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts. J Exp Med 1979; 150:1098-107.
10. Abraham EC, Perry RE, Stallings M. Application of affinity chromatography for separation and quantitation of glycosylated hemoglobins. J Lab Clin Med 1983; 102:187-97.
11. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J Biol Chem 1991; 266:7329-32.
12. Nakayama H, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Itoh T, Nakagawa S. Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes 1993; 42:345-50.
13. Swamy MS, Abraham EC. Lens protein composition, glycation and high molecular weight aggregation in aging rats. Invest Ophthalmol Vis Sci 1987; 28:1693-701.
14. Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE, Trevithick JR. Modelling cortical cataractogenesis VIII: effects of butylated hydroxytoluene (BHT) in reducing protein leakage from lenses in diabetic rats. Exp Eye Res 1986; 43:305-14.
15. Merck KB, de Haard-Hoekman WA, Cruysberg JR, Bloemendal H, de Jong WW. Characterization of anti-crystallin auto-antibodies in patients with cataract. Mol Biol Rep 1993; 17:93-9.
16. Chylack LT Jr, Singh DP, Kikuchi T, Sueno T, Wolfe J, Shinohara T. Human sera obtained from patients with cataract killed lens epithelial cells in culture. Invest Ophthalmol Vis Sci 1996; 37:S1142.
17. Angunawela II. The role of autoimmune phenomena in the pathogenesis of cataract. Immunology 1987; 61:363-8.
18. Angunawela II. The effects of immunosuppression on the development of (experimental) cataract. Immunology 1988; 64:69-72.
19. Ogha H, Katyama T, Egi K, Fujiwara H. Ocular Immunology Today. In: Ususi M, Ohno S, Aoki K, editors. Proceedings of the 5th International Symposium on the Immunology and Immunopathology of the Eye, Tokyo, 13-15 March 1990. Amsterdam: Elsevier Science; 1990. p. 391-4.
20. Patel M, Shine B, Murray PI. Antilens antibodies in cataract and inflammatory eye disease: an evaluation of a new technique. Int Ophthalmol 1990; 14:97-100.
21. Nissen SH, Andersen P, Andersen HM. Antibodies to lens antigens in cataract and after cataract surgery. Br J Ophthalmol 1981; 65:63-6.
22. Ibaraki N, Lin LR, Dang L, Reddy VN, Singh DP, Sueno T, Chylack LT Jr, Shinohara T. Anti-beta-crystallin antibodies (mouse) or sera from humans with age-related cataract are cytotoxic for lens epithelial cells in culture. Exp Eye Res 1997; 64:229-38.
23. Sueno T, Inoue E, Singh DP, Awata T, Chylack LT Jr, Shinohara T. Oral administration of lens homogenate suppresses antibody production in mice injected with beta-crystallin emulsified in CFA. Exp Eye Res 1997; 64:379-85.
24. Sandberg HO, Closs O. Radioimmunoassay of sheep alpha- and gamma-crystallins II. Organ specificity of lens crystallins. Exp Eye Res 1978; 27:73-80.
25. Kyselova Z, Gajdosik A, Gajdosikova A, Ulicna O, Mihalova D, Karasu C, Stefek M. Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. Mol Vis 2005; 11:56-65.
26. Ranjan M, Beedu SR. Spectroscopic and biochemical correlations during the course of human lens aging. BMC Ophthalmol 2006; 6:10.
27. Lott JA, Turner K. Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem 1975; 21:1754-60.
28. Bunn HF. Evaluation of glycosylated hemoglobin diabetic patients. Diabetes 1981; 30:613-7.
29. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25:192-205.
30. Tate SS, Meister A. Interaction of gamma-glutamyl transpeptidase with amino acids, dipeptides, and derivatives and analogs of glutathione. J Biol Chem 1974; 249:7593-602.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
32. Nakayama H, Taneda S, Kuwajima S, Aoki S, Kuroda Y, Misawa K, Nakagawa S. Production and characterization of antibodies to advanced glycation products on proteins. Biochem Biophys Res Commun 1989; 162:740-5.
33. Nakayama H, Taneda S, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Misawa K, Yanagisawa K, Nakagawa S. Characterization of antibodies to advanced glycosylation end products on protein. J Immunol Methods 1991; 140:119-25.
34. Bhat KS. Alterations in the lenticular proteins of rats on riboflavin deficient diet. Curr Eye Res 1982-83; 2:829-34.
35. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 1992; 267:10211-4.
36. Sashidhar RB, Capoor AK, Ramana D. Quantitation of epsilonamino group using amino acids as reference standards by trinitrobenzene sulfonic acid. A simple spectrophotometric method for the estimation of hapten to carrier protein ratio. J Immunol Methods 1994; 167:121-7.
37. Harlow E, Lane D, editors. Antibodies: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1988. p. 298-303.
38. Nayak S, Sashidhar RB, Bhat KS. Development of an immunoanalytical method for the detection of beta- and gamma-crystallins and anti-crystallin antibodies. A molecular biomarker for cataract. Indian J Ophthalmol 2002; 50:41-8. Erratum in: Indian J Ophthalmol 2002; 50:81.
39. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76:4350-4.
40. Swamy-Mruthinti S, Shaw SM, Zhao HR, Green K, Abraham EC. Evidence of a glycemic threshold for the development of cataracts in diabetic rats. Curr Eye Res 1999; 18:423-9.
41. Lou MF, Dickerson JE Jr, Garadi R, York BM Jr. Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res 1988; 46:517-30.
42. Perry RE, Swamy MS, Abraham EC. Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp Eye Res 1987; 44:269-82.
43. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38:535-9.
44. Swamy-Mruthinti S, Green K, Abraham EC. Inhibition of cataracts in moderately diabetic rats by aminoguanidine. Exp Eye Res 1996; 62:505-10.
45. Abraham EC, Swamy MS, Perry RE. Nonenzymatic glycosylation (glycation) of lens crystallins in diabetes and aging. Prog Clin Biol Res 1989; 304:123-39.
46. Russell P, Smith SG, Carper DA, Kinoshita JH. Age and cataract-related changes in the heavy molecular weight proteins and gamma crystallin composition of the mouse lens. Exp Eye Res 1979; 29:245-55.
47. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40:405-12.
48. Brennan M. Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J Biol Chem 1989; 264:20947-52.
49. Cloos PA, Christgau S. Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 2004; 5:139-58.
50. Newkirk MM, Goldbach-Mansky R, Lee J, Hoxworth J, McCoy A, Yarboro C, Klippel J, El-Gabalawy HS. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res Ther 2003; 5:R82-90.